SUBSCRIBE
SUBSCRIBE

Valeant Pharmaceuticals International

NEWS
Valeant Pharmaceuticals International was acquired by Bausch & Lomb in 2013.
Genetown
Five Lessons Big Pharma Should Learn From Valeant’s Collapse
March 18, 2016
 · 
1 min read
Former Valeant CEO Nabs $9+ Million Severance Deal and Consulting Role
Business
Valeant CEO Reassures Employees Firm Isn’t Going Broke Even After Stock Continues its Nosedive
March 18, 2016
 · 
2 min read
Former Valeant CEO Nabs $9+ Million Severance Deal and Consulting Role
Business
Valeant CEO Lays Out Strategy to Staff, Says ‘No Other Shoe Expected to Drop’
March 11, 2016
 · 
2 min read
Business
Valeant Reassures Investors Top Dermatology Exec Resigned, Was Not Let Go As Part of Philidor Fallout
March 4, 2016
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Biotech Beach
Embattled Valeant Quietly Schedules Then Cancels Call with Analysts
March 1, 2016
 · 
3 min read
Business
Valeant CEO Pearson Returns, But Company Still Faces Numerous Challenges
February 29, 2016
 · 
3 min read
Business
Valeant CEO Pearson Ready to Return But Board is Debating Whether He Should
February 25, 2016
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Policy
As Valeant Drops $6 Billion+ in Value Over Four Days, Report Shows Interim CEO Used Company Jet for Vacation
February 23, 2016
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Valeant Uses Rare Accounting Move to Hide the True Details of Complex Deals
February 12, 2016
 · 
3 min read
Load More
IN THE PRESS
Business
Valeant Announces Licensing Agreement With Norgine For NER1006 In U.S. And Canada
August 8, 2016
 · 
6 min read
Business
Embattled Valeant Shakes Up Executive Team in Strategic Plan to Create a Whole New Company
August 8, 2016
 · 
6 min read
Policy
Why Wall Street Can’t Stop Talking About Potential ‘Baby Valeant’ Concordia
August 3, 2016
 · 
1 min read
How Valeant Cashed in Twice on Hiking Drug Prices
August 1, 2016
 · 
1 min read
Business
Valeant Announces The Addition Of Sarah B. Kavanagh To Its Board Of Directors
July 29, 2016
 · 
3 min read
FDA
FDA Panel Says Valeant’s Psoriasis Med Should be Approved with Risk Plan
July 20, 2016
 · 
5 min read
FDA
Valeant, Progenics Shares Climb on Constipation Drug Approval
July 20, 2016
 · 
9 min read
Business
Valeant Announces Second Quarter Results Conference Call Date And Details
July 15, 2016
 · 
1 min read
Valeant Comments On Recent Stock Transactions
July 14, 2016
 · 
3 min read
Valeant Falls as Second Largest Investor Dumps Entire Stake, Citron’s Left and Ex-CEO Make Moves
July 14, 2016
 · 
1 min read
Load More